NF-κB plays an essential role in the modulation of PAH 27-32, and NF-κB activation is one of the primary hypoxia-driven signals to promote pulmonary arterial obliteration, inflammation, and reduced immune regulation in the context of severe obliterative PAH 33. This evidence concerns the gene NFKB1 and pulmonary arterial hypertension.